Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments. This report contains market size and forecasts of Medical 3D Bioprinting in Global, including the following market information: Global Medical 3D Bioprinting Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Medical 3D Bioprinting market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. SLA Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Medical 3D Bioprinting include 3D Systems, GE Healthcare, ExOne, Electro Optical Systems, Renishaw, Stratasys, EnvisionTEC, Cyfuse Biomedical and Formlabs, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical 3D Bioprinting companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Medical 3D Bioprinting Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Medical 3D Bioprinting Market Segment Percentages, by Type, 2021 (%) SLA FDM LOM Others Global Medical 3D Bioprinting Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Medical 3D Bioprinting Market Segment Percentages, by Application, 2021 (%) Medical Device Manufacturers Pharmaceutical Companies Others Global Medical 3D Bioprinting Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Medical 3D Bioprinting Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Medical 3D Bioprinting revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Medical 3D Bioprinting revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: 3D Systems GE Healthcare ExOne Electro Optical Systems Renishaw Stratasys EnvisionTEC Cyfuse Biomedical Formlabs Organovo Holdings Allevi Advanced Solutions Aspect Biosystems CELLINK GeSiM Bio3D Technologies Regenovo Biotechnology Optomec Mecuris Fluicell BigRep
1 Introduction to Research & Analysis Reports 1.1 Medical 3D Bioprinting Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Medical 3D Bioprinting Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process
